Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^* Pineiro Dagnery Juan Manuel	2. Issuer Name and Ticker or Trading Symbol LifeMD, Inc. [ LFMD ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) Former Chief Revenue Officer
(Last) (First) (Middle) C/O LIFEMD, INC, 800 THIRD AVENUE,, SUITE 2800	3. Date of Earliest Transaction (MM/DD/YYYY) 2/9/2021
(Street) NEW YORK, NY 10022 (City) (State) (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock, par value $0.001	2/9/2021		M		9625 ⁽¹⁾	A	$26.65	54625	D
Common Stock, par value $0.001	2/9/2021		M		13874 ⁽²⁾	A	$26.65	68499	D
Common Stock, par value $0.001	2/9/2021		M		59421 ⁽³⁾	A	$26.65	127920	D
Common Stock, par value $0.001	4/2/2021		M		4262 ⁽⁴⁾	A	$17.26	132182	D
Common Stock, par value $0.001	4/2/2021		A		10000	A	$0 ⁽⁵⁾	142182	D

*Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)*
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)			11. Nature of Indirect Beneficial Ownership (Instr. 4)
Options to purchase Common Stock	$26.65	2/9/2021		M			9625 ⁽¹⁾	⁽¹⁾	⁽¹⁾	Common Stock, par value $0.001	9625	$0	15000	D
Options to purchase Common Stock	$26.65	2/9/2021		M			13874 ⁽²⁾	⁽²⁾	⁽²⁾	Common Stock, par value $0.001	13874	$0	0	D
Options to purchase Common Stock	$26.65	2/9/2021		M			59421 ⁽³⁾	⁽³⁾	⁽³⁾	Common Stock, par value $0.001	59421	$0	37900	D
Options to purchase Common Stock	$17.26	4/2/2021		M			4262 ⁽⁴⁾	⁽⁴⁾	⁽⁴⁾	Common Stock, par value $0.001	4262	$0	0 ⁽⁶⁾	D

Explanation of Responses:
(1)	Represents a cashless exercise of outstanding stock options to purchase 10,000 shares of common stock. Mr. Pineiro Dagnery received 9,625 shares of common stock and surrendered 375 shares of common stock underlying the option in payment of the exercise price. The options were issued to Mr. Pineiro Dagnery pursuant to the former Consultant Agreement by and between Mr. Pineiro Dagnery and the Issuer.
(2)	Represents a cashless exercise of outstanding stock options to purchase 15,000 shares of common stock. Mr. Pineiro Dagnery received 13,874 shares of common stock and surrendered 1,126 shares of common stock underlying the option in payment of the exercise price. The options were issued to Mr. Pineiro Dagnery pursuant to the former Consultant Agreement by and between Mr. Pineiro Dagnery and the Issuer.
(3)	Represents a cashless exercise of outstanding stock options to purchase 62,100 shares of common stock. Mr. Pineiro Dagnery received 59,421 shares of common stock and surrendered 2,680 shares of common stock underlying the option in payment of the exercise price. The Options were issued to Mr. Pineiro Dagnery pursuant to the former Employment Agreement by and between Mr. Pineiro Dagnery and the Issuer.
(4)	Represents a cashless exercise of outstanding stock options to purchase 4,566 shares of common stock. Mr. Pineiro Dagnery received 4,262 shares of common stock and surrendered 304 shares of common stock underlying the option in payment of the exercise price. The Options were issued to Mr. Pineiro Dagnery pursuant to the former Employment Agreement by and between Mr. Pineiro Dagnery and the Issuer.
(5)	On April 2, 2021 (the "Effective Date"), Mr. Pineiro Dagnery and the Issuer entered into a Resignation and Release Agreement, whereby in connection with his resignation as Chief Revenue Officer of the Issuer (the "Resignation"), Mr. Pineiro Dagnery will receive, within sixty (60) of the Effective Date, equity severance of 10,000 shares of common stock of the Company (the "Severance Shares").
(6)	On March 31, 2019, in connection with his appointment as Chief Financial Officer of the Company, Mr. Pineiro Dagnery received options to purchase 100,000 shares of common stock of the Issuer (the "Options"). 33,333 Options vested on April 1, 2020. 33,333 Options vested on April 1, 2021. On the Effective Date and in connection with the Resignation, the remaining 33,334 unvested Options were forfeited.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Pineiro Dagnery Juan Manuel C/O LIFEMD, INC, 800 THIRD AVENUE, SUITE 2800 NEW YORK, NY 10022			Former Chief Revenue Officer